BOISE, Idaho (AP) — A global pharmaceutical company has agreed to pay Idaho $47,000 to settle a fraud lawsuit over a prescription drug for treating multiple sclerosis.
Idaho Attorney General Lawrence Wasden announced the settlement Wednesday. Idaho's case is part of bigger lawsuit involved several states and the federal government against EMD Serono Inc. The company makes Rebif, a prescription drug used to treat relapsing forms of multiple sclerosis.
State and federal attorneys alleged the company made inappropriate payments to hundreds of doctors for prescribing Rebif between 2002 and 2009.
Of Idaho's share, more than $18,000 will go to the state Medicaid program as restitution, while the additional $28,000 will go into the state's general fund.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
